News
Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
Tue, 01/26/2010 - 7:52am
Patients with moderate or severe hepatic impairment should be treated with reduced starting doses and closely monitored.
Topics
